Meronem

Meropenem, the active ingredient in Meronem, is a carbapenem antibiotic presented as an injectable solution for intravenous use. It is employed to treat serious bacterial infections such as complicated intra‑abdominal infections, urinary tract infections, hospital‑acquired and ventilator‑associated pneumonia, severe sepsis, septic shock, and meningitis caused by susceptible organisms in hospitalized patients.

GNH USA supplies Meronem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Meropenem is a broad‑spectrum carbapenem used for serious bacterial infections affecting various organ systems.

- Complicated intra‑abdominal infections: achieves clinical cure and bacterial eradication. - Complicated urinary tract infections: provides effective bacterial clearance. - Hospital‑acquired pneumonia: improves respiratory infection outcomes. - Ventilator‑associated pneumonia: supports recovery in ventilated patients. - Severe sepsis and septic shock: contributes to rapid infection control. - Meningitis caused by susceptible organisms: penetrates the CSF to treat central nervous system infections.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: may be watery and self‑limited. - Vomiting: occasional emesis during infusion. - Headache: transient cranial discomfort. - Infusion site reactions: erythema or phlebitis at the injection site. - Rash: mild skin eruptions.

Serious or Rare Side Effects: - Seizures: especially in patients with CNS disorders or renal impairment. - Anaphylaxis: acute, potentially life‑threatening allergic reaction. - Clostridioides difficile‑associated diarrhea: severe colitis risk. - Nephrotoxicity: renal function decline in susceptible individuals. - Neutropenia: reduced white blood cell count. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Meropenem should be used with careful clinical monitoring. - Renal impairment: adjust dose based on creatinine clearance. - History of seizures: monitor neurologic status closely. - Hypersensitivity to beta‑lactams: avoid use if allergic reactions have occurred. - C. difficile infection risk: assess for signs of colitis during therapy. - Concomitant nephrotoxic drugs: evaluate renal function regularly. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meropenem may interact with several medications; monitoring is advised.

Major Interactions (Avoid): - Valproic acid: meropenem reduces plasma levels, increasing seizure risk. - Probenecid: may increase meropenem concentrations, heightening toxicity.

Moderate Interactions (Monitor Closely): - Aminoglycosides: combined nephrotoxic potential; monitor renal function. - Loop diuretics: may exacerbate renal impairment. - Warfarin: possible INR fluctuations; check coagulation status. - Oral contraceptives: reduced efficacy reported; advise alternative contraception.